Suzhou Highfine Biotech Co., Ltd. (SZSE: 301393)
Health Care · Pharmaceuticals · CN
CN¥68.20
+3.85% today · +14.4% 1Y
Suzhou Highfine Biotech Co., Ltd. (SZSE: 301393) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.08B.
Over the last twelve months the share price has gained 14.4%, trading between 46.69 and 74.68.
Tweenvest scores Suzhou Highfine Biotech Co., Ltd. across four factors: quality 70/100, value 38/100, growth 61/100, dividend 15/100. Its strongest factor is quality.
301393 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.08B
- Revenue (TTM)
- $92.64M
- P/E
- 64.90
- EPS
- 1.05
- Dividend yield
- 0.59%
- Beta (5Y)
- 0.63
- 52-week high
- CN¥74.68
- 52-week low
- CN¥46.69
- Avg volume (3M)
- —
- Shares outstanding
- 107.18M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,247.37 | -0.64% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.00 | +1.02% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.91 | -1.08% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.03 | -0.14% |
Figures last refreshed Aug 18, 2026.